Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2021 Jul 1;290(1):238. doi: 10.1111/joim.13289

Corrigendum

PMCID: PMC8451055  PMID: 34196440

In the article [1], there is an error in the author byline on page 369. The affiliation of G. M. C. Rosano is incorrect and should have been corrected.

The incorrect affiliation reads:

Department of Medical Sciences, IRCCS San Raffaele, Rome, Italy; and Cardiology Clinical Academic Group, St George’s Hospitals NHS Trust University of London, London, UK.

The correct affiliation should be:

Centre for Clinical and Basic Research, Department of Medical Sciences, IRCCS San Raffaele Pisana, Rome, Italy.

We apologize for this error.

Reference

  • 1.Savarese G, Hage C, Benson L, Schrage B, Thorvaldsen T, Lundberg A, Fudim M, Linde C, Dahlström U, Rosano GMC. Lund, LH Eligibility for sacubitril/valsartan in heart failure across the ejection fraction spectrum: real‐world data from the Swedish Heart Failure Registry. J Intern Med. 2021;289:369–384. 10.1111/joim.13165. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Internal Medicine are provided here courtesy of Wiley

RESOURCES